BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
 | Browse: 444 | Download: 474
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 7999
Country/Territory
Received
2013-12-11 09:32
Peer-Review Started
2013-12-11 16:17
To Make the First Decision
2014-01-16 08:13
Return for Revision
2014-01-17 13:12
Revised
2014-02-08 21:31
Second Decision
2014-05-08 17:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-08 17:52
Articles in Press
2014-05-23 12:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-08-01 15:04
Publish the Manuscript Online
2014-09-04 09:25
ISSN 2150-5349 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Renal dysfunction in patients with cirrhosis: Where do we stand?
Manuscript Source Invited Manuscript
All Author List Chrysoula Pipili and Evangelos Cholongitas
Funding Agency and Grant Number
Corresponding Author Evangelos Cholongitas, Senior Lecturer of Internal Medicine, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49, Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr
Key Words Renal dysfunction; Cirrhosis; Assessment; Management; Hepatorenal syndrome
Core Tip Close surveillance, well -classified definitions and scoring systems will be helpful in recognizing the renal dysfunction. Noninvasive biomarkers (NGAL, sCysC) reflect the prospective method in identifying kidney damage and kidney function. The acute renal function is proposed to be assessed with modified acute kidney injury network (AKIN) and the baseline renal function in stable patients with MDRD-6 formula or chronic kidney disease epidemiology collaboration Cys C-Cr equation. MBRS score or RIFLE criteria for AKI evaluation should be tried in critically ill cirrhotic patients, while in candidates for transplantation, glomerular filtration rate should be preferably measured with exogenous markers for accurate assessment of renal function. Amelioration of the underlined liver disease is very impressive in patients with alcoholic liver disease after recovery from alcoholic hepatitis, and in patients with decompensated cirrhosis due to hepatitis B virus infection after receiving antiviral therapy.
Publish Date 2014-09-04 09:25
Citation Pipili C, Cholongitas E. Renal dysfunction in patients with cirrhosis: Where do we stand? World J Gastrointest Pharmacol Ther 2014; 5(3): 156-168
URL http://www.wjgnet.com/2150-5349/full/v5/i3/156.htm
DOI http://dx.doi.org/10.4292/wjgpt.v5.i3.156
Full Article (PDF) WJGPT-5-156.pdf
Full Article (Word) WJGPT-5-156.doc
Manuscript File 7999-Review.doc
Answering Reviewers 7999-Answering reviewers.pdf
Copyright License Agreement 7999-Copyright assignment.pdf
Peer-review Report 7999-Peer review(s).pdf
Scientific Editor Work List 7999-Scientific editor work list.pdf